Cancer Cachexia Clinical Trials

9 recruitingLast updated: June 17, 2026

There are 9 actively recruiting cancer cachexia clinical trials across 8 countries. Studies span Phase 1, Phase 2, Not Applicable. Top locations include Appleton, Wisconsin, United States, Baltimore, Maryland, United States, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Cancer Cachexia Trials at a Glance

9 actively recruiting trials for cancer cachexia are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Phase 1 with 3 trials, with the heaviest enrollment activity in Appleton, Baltimore, and Beijing. Lead sponsors running cancer cachexia studies include University of Erlangen-Nürnberg Medical School, Hasselt University, and H. Lee Moffitt Cancer Center and Research Institute.

Browse cancer cachexia trials by phase

Treatments under study

About Cancer Cachexia Clinical Trials

Looking for clinical trials for Cancer Cachexia? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cancer Cachexia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cancer Cachexia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Effects of Dietary Supplementation With omega3-fatty Acids (Fish Oil) and Progressive Resistance Training on Skeletal Muscle Status in Gynaecological, Gastrointestinal and Urological Cancer Patients

muscle wastingCancerResistance Training+3 more
University of Erlangen-Nürnberg Medical School288 enrolled1 locationNCT07643558
Recruiting
Phase 1Phase 2

A Study of JMT203 in Patients With Cancer Cachexia

Pancreatic CancerNon-small Cell Lung CancerCancer Cachexia+2 more
Shanghai JMT-Bio Inc.307 enrolled1 locationNCT06868849
Recruiting
Phase 2

An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

Colorectal, CancerCancer CachexiaCRC (Colorectal Cancer)
NGM Biopharmaceuticals, Inc136 enrolled28 locationsNCT07033026
Recruiting
Phase 2

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

Cancer of the BreastCancerAdjustment Disorder+8 more
Psyence Australia Pty Ltd87 enrolled3 locationsNCT07072728
Recruiting

A First-in-Human Study of FID-022 in Solid Tumor Patients

Pancreatic CancerCancer Cachexia
H. Lee Moffitt Cancer Center and Research Institute120 enrolled1 locationNCT07249775
Recruiting
Not Applicable

Flexi Band Resistance Training Versus EMS Exercise in Patients With the Diagnosis of Malignant Diseases

CancerCancer CachexiaInflammation+1 more
University of Erlangen-Nürnberg Medical School100 enrolled1 locationNCT04067167
Recruiting
Phase 1

To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy Participants

Cancer cachexia syndromeCancer CachexiaCancer Cachexia (CC)
Shenzhen Kexing Pharmaceutical Co., Ltd.36 enrolled1 locationNCT07237464
Recruiting

Structural Characteristics of Trunk and Limb Muscles in Cachectic Colorectal Cancer Patients

Colorectal, CancerCancer Cachexia
Hasselt University60 enrolled2 locationsNCT06780423
Recruiting
Phase 1

A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or Cachexia

Cancer Cachexia
Genfleet Therapeutics (Shanghai) Inc.36 enrolled1 locationNCT06898255